ImmunoGen ( IMGN) is focused on the development of therapeutics for the treatment of cancer using cancer biology, monoclonal antibodies and small molecule cytotoxic or cell-killing, agents. This stock is trading up 3.4% at $17.93 in recent trading.
Today's Volume: 553,000
Average Volume: 756,459
Volume % Change: 50%
Average Volume: 75,759
Volume % Change: 100% >>5 Rocket Stocks to Buy for July From a technical perspective, is trending modestly higher here right above some key near-term support at $43 with above-average volume. This stock has been uptrending incredibly strong for the last month, with shares soaring higher from its low of $30.73 to its recent high of $45. During that uptrend, shares of ICPT have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of ICPT within range of triggering a major breakout trade, which will hit if ICPT manages to take out its all-time high at $45 with high volume.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts